Regulation

This week's top stories include the CMS ups penalties for hospitals ignoring the price transparency rule, the ATA and other groups ask Congress to safeguard telehealth for workers, and senior assistance company Papa raises $150 million in Series D funding.

HIMSS Senior VP of Government Relations Tom Leary provides updates on Patient ID Now, pandemic response and the telehealth cliff at HIMSS21.

This week's top stories include the Patient ID Now coalition pushing for a national patient ID strategy, President Biden looking to lower ACA premiums and drug costs, and Accolade moving into the telemedicine space with PlushCare acquisition.

This week's top stories include the Peloton Tread+ coming under fire, nurses giving EHR usability an "F" and HHS vowing to tackle racism as a serious public health threat.

This week's top stories include Biden appointing Jeffrey Zients as head of the White House's COVID-19 response team and Micky Tripathi as head of National Coordinator for Health IT, while YouTube taps Dr. Graham to lead its health partnerships team.

Tom Leary, SVP of government relations at HIMSS, says the presidential election has passed, but ongoing Senate races could have unforeseen impacts on healthcare IT.

This week's top stories include the Supreme Court appearing favorable to keeping the Affordable Care Act, Google Cloud unveiling AI tools for analyzing unstructured medical text, and Epic customers gaining access to a COVID-19 risk prediction model.

This week's top stories include HHS requiring hospitals to report flu data, Americans wanting mental healthcare via telehealth, and Clover Health joining the public market by merging with Social Capital SPAC.

This week's top stories include a look at what the death of Supreme Court Justice Ginsburg could mean for the Affordable Care Act, femtech companies finding it difficult to advertise on social media and the emergence of social informatics.

Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the FDA's role in balancing innovation, regulation and safety during the coronavirus pandemic.